ABSTRACT
II. Social Issues............................................................................................................. 176
III. Hallucinogenic Amphetamine Analogues................................................................ 178
IV. Toxicity..................................................................................................................... 179
V. MDMA..................................................................................................................... 181
VI. Research Concerns................................................................................................... 182
References............................................................................................................................184
